Award Recipients Announced for the 2023 San Antonio Breast Cancer Symposium
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
AACR expresses appreciation to Monica Bertagnolli, MD, for her stewardship of NCI before becoming NIH director in early November PHILADELPHIA...
PHILADELPHIA – The American Association for Cancer Research (AACR) and the St. Baldrick’s Foundation today announced that Alanna Joyce...
Fewer than half of patients with unsatisfactory samples from fecal immunochemical tests completed follow-up testing within 15 months PHILADELPHIA...
PHILADELPHIA – Philip D. Greenberg, MD, FAACR, President of the American Association for Cancer Research (AACR), and Margaret Foti,...
Cancer patients eligible for precision oncology therapies nearly doubled between 2017 and 2022 PHILADELPHIA – Of the 198 new...
The therapy uses a different mechanism than approved KRAS G12C inhibitors and targets multiple RAS mutations beyond KRAS G12C...
Second-generation PRMT5 inhibitor targets synthetic lethality in several cancer types with MTAP loss BOSTON – AMG 193, a second-generation...
PHILADELPHIA – The American Association for Cancer Research (AACR) extends its warmest congratulations to the 15 AACR members who...
Today, the American Association for Cancer Research (AACR) issued the following statement regarding the death of Senator Dianne Feinstein:...